Indefinite Delivery Contract SPE2DR25D1202

The federal contract IDV award is an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The contract covers an extensive array of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract has a 30-month base period and three 30-month option periods, resulting in a total estimated value of $30.3 billion. This IDC serves as a primary vehicle for DLA Troop Support to procure essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism. The contract is awarded on a regional basis, with the intent to have at least three different contractors to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters.

The original solicitation describes the DLA Troop Support Medical's plan to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The procurement will be fully competitive, with awards made to responsive and responsible offerors whose proposals are technically acceptable and offer the lowest overall price based on distribution fees. Both primary and backup suppliers will be selected, with separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally. This requirements-type contract is expected to cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code (NDC) database.